Lorvotuzumab MMAE
Product Specifications
Bioactivity
Lorvotuzumab-MMAE, an antibody-drug conjugate (ADC), comprises a neural cell adhesion molecule (NCAM) -targeted antibody linked to Monomethyl auristatin E (MMAE), and is utilized in the research of multiple myeloma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog